-
Consumer Insights
NewCost Pressures – Shopping Trends and Consumer Insights
Cost Pressures Market Report Overview Consumers across the globe are pessimistic about their country’s economic scenario over the next six months. However, a significant part of the population believe the economies to decline in the coming years. The economic adversities will adversely impact retail spending as consumers plan to cutback on costs. Retailers should opt for cost-effective alternatives, with a focus on promoting value for money, to drive retail spending. Consumers are changing their purchasing patterns in response to inflationary...
-
Sector Analysis
Positive Airway Pressure Devices Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Positive Airway Pressure Devices Market Report Overview The positive airway pressure devices market size was $2.44 billion in 2023. The market is expected to grow at a CAGR of more than 7% during 2023-2033. Positive airway pressure (PAP) is a method of respiratory ventilation used primarily in the treatment of sleep apnea. PAP ventilation can also be used during the "weaning off" period of a ventilated intensive care patient, in exacerbations of Chronic Obstructive Pulmonary Disease (COPD), pulmonary edema, and...
-
Product Insights
NewLikelihood of Approval Analysis for Hypertension
Overview How likely is it that the drugs in Hypertension will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypertension Overview Hypertension, commonly known as high blood pressure, is a chronic medical...
-
Product Insights
NewLikelihood of Approval Analysis for Ocular Hypertension
Overview How likely is it that the drugs in Ocular Hypertension will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ocular Hypertension Overview Ocular hypertension occurs when the pressure inside the eye...
-
Product Insights
NewLikelihood of Approval Analysis for Open-Angle Glaucoma
Overview How likely is it that the drugs in Open-Angle Glaucoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Open-Angle Glaucoma Overview Open-angle glaucoma is a chronic eye condition characterized by...
-
Product Insights
NewLikelihood of Approval Analysis for Atrial Fibrillation
Overview How likely is it that the drugs in Atrial Fibrillation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atrial Fibrillation Overview Atrial fibrillation is an irregular and often rapid heart...
-
Product Insights
NewLikelihood of Approval Analysis for Glaucoma
Overview How likely is it that the drugs in Glaucoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Glaucoma Overview Glaucoma is a disease of the eye in which fluid pressure...
-
Product Insights
NewLikelihood of Approval Analysis for Shock
Overview How likely is it that the drugs in Shock will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Shock Overview Shock is a medical condition characterized by a significant and life-threatening...
-
Product Insights
NewLikelihood of Approval Analysis for Paraganglioma (Glomus Jugulare Tumor)
Overview How likely is it that the drugs in Paraganglioma (Glomus Jugulare Tumor) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paraganglioma (Glomus Jugulare Tumor) Overview Abnormal growth of chromaffin cells,...
-
Product Insights
NewLikelihood of Approval Analysis for Adrenal Gland Cancer
Overview How likely is it that the drugs in Adrenal Gland Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenal Gland Cancer Overview Adrenal gland cancer is a rare type...